Patent ID: 8672863
Filing Date: 2014-03-18
Classification: A61B,A61K

Abstract:
1. A method for indicating transferability of a non-dissolvable target in-vivo device through the gastrointestinal tract, the method comprising: ingesting a dissolvable in-vivo device having initial dimensions similar to the dimensions of said non-dissolvable target in-vivo device, said dissolvable in-vivo device comprising: inducing the dissolvable in-vivo device to send a signal, including after a predetermined time period, said predetermined time period being longer than the time the target in-vivo device typically takes to pass through a transferable GI tract; and determining transferability of the target in-vivo device through the gastrointestinal tract, wherein receiving a signal from said monitoring mechanism after said predetermined time period is an indication of the presence of said dissolvable in-vivo device within the GI tract, which indicates abnormalities in the GI tract, and wherein not receiving a signal from said monitoring mechanism after said predetermined time period is an indication of said dissolvable in-vivo device not being present within the GI tract, which indicates transferability of the target in-vivo device through the GI tract.